名稱 | PD-L1 aAPC Cell IO細(xì)胞株 |
型號(hào) | CBP74164 |
報(bào)價(jià) | ![]() |
特點(diǎn) | PD-L1 aAPC Cell |
產(chǎn)品搜索
相關(guān)文章
- IgE:過敏與免疫的“雙面分子”
- 熱門CTLA4&PD1/L1雙靶點(diǎn)抗體活性檢測(cè)細(xì)胞模型
- 【靶點(diǎn)模型】AKT基因的藥物開發(fā)
- 【產(chǎn)品推介】腫瘤融合基因檢測(cè)及靶向治療
- 【連載-企業(yè)參考品】 神經(jīng)膠質(zhì)瘤的診斷參考品的選擇
- ADCC/ADCP細(xì)胞篩選模型
- Cell Rep:發(fā)現(xiàn)治療乳腺癌轉(zhuǎn)移的重要新靶標(biāo)!
- 腫瘤細(xì)胞分裂“制動(dòng)系統(tǒng)”相關(guān)基因分析
- NK細(xì)胞激活總開關(guān):NKG2D
- 【靶點(diǎn)模型+診斷質(zhì)控】FLT3-ITD的藥物開發(fā)和診斷
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74164PD-L1 aAPC Cell IO細(xì)胞株

- 詳細(xì)內(nèi)容
CBP74164 | |
I. Background | |
The binding of Programmed Cell Death Protein 1 (PD-1), a receptor expressed on activated T-cells, to its ligands, PD-L1 and PD-L2, negatively regulates immune responses. The PD-1 ligands are found on most cancers, and PD-1:PD-L1/2 interaction inhibits T cell activity and allows cancer cells to escape immune surveillance. The PD-1:PD-L1/2 pathway is also involved in regulating autoimmune responses, making these proteins promising therapeutic targets for a number of cancers, as well as multiple sclerosis, arthritis, lupus, and type I diabetes. | |
II. Introduction | |
Expressed gene: | PDL1 |
Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | RPMI-1640+10%FBS+1ug/ml puromycin+200ug/ml hygromycin |
Mycoplasma Testing: | Negative |
Storage: | Liquid nitrogen |
Application(s): | Functional(Report Gene) Assay |
III. Representative Data | |
Figure 1. Dose Response of Blocking Antibodies in PD-1/OX40 Dual Effector Reporter Cells (C22) With PD-L1 aAPC Cells. | |